Nautilus Biotechnology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $85.0M
Liabilities Breakdown FY2020
Total Liabilities: $6.3M
Asset Breakdown
Total Assets: $85.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $36.6M | 43.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.4M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $47.0M | 55.3% |
Liabilities Breakdown
Total Liabilities: $6.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $470.0K | 7.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.8M | 92.6% |